# Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections

> **NCT03160807** · PHASE4 · UNKNOWN · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 214 (estimated)

## Conditions studied

- Urinary Tract Infection

## Interventions

- **DRUG:** Levofloxacin
- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT03160807
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-15
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 214 (ESTIMATED)
- **Last updated:** 2017-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03160807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03160807, "Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03160807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*